Nell'ambito del progetto di ricerca dal titolo “Studio di attività ...

More documents

Recommendations

Info

$3Eterov e)ce(te/rou sofo\v to/ te pa/lai to/ te nu=n. Ou ... - EleA@UniSA$

Elenco abbreviazioni _____________________________________________________________ Elenco abbreviazioni ABC: ATP-Binding Cassette ACTA1: Actin Alpha1 Ac2-26: NH2-terminal mimetic peptide ANXA1 ALXR: Lipoxin A4 Receptor ANXA1: annexin A1 AP-1: Activator Protein-1 ARO: Anaplastic thyroid carcinoma cells ATP: Adhenosine TriPhosphate BLBC: Basal-Like Breast Cancer cells BM: Bone Marrow BrdU: BromodeoxyUridine CAV3: Caveolin-3 CFTD: Congenital Fiber Type Disproportion CK: Creatine Kinase CKB: Creatine Kinase B COX-2: Ciclooxygenase 2 cPLA2: Cytosolic phospholipase A2 CRYAB: AlphaB-Crystallin DA: Distal Arthrogryposis DA2A: Distal Arthrogryposis type 2A DA2B: Distal Arthrogryposis type 2B DA7: Distal Arthrogryposis type 7 DAPC: Dystrophin-Associated Protein Complex DES: Desmin DM: Differentiation Medium DMD: Duchenne Muscular Dystrophy EDMD: Emery-Dreifuss Muscular Dystrophy ERK: Extracellular signal-Regulated Kinase FGF: Fibroblast Growth Factor FLNC: Filamin C fMLP: formylMethionylLeucylPhenylalanine - 8 -
FPR: Formil Peptide Receptor FPRL-1: Formil Peptide Receptor Like type 1 FPRL-2: Formil Peptide Receptor Like type 2 FRO: Follicular undifferentiated thyroid carcinoma cells FTC: Follicular Thyroid Cancer GAP: GTPase Activating Protein GFP: Green Fluorescent Protein GM: Growth Medium GPCR: G Protein Coupled Receptor HFF: Human Foreskin Fibroblast HGF: Hepatocyte Growth Factor HL-60: Human promyelocytic Leukemia HSP: Heat Shock Protein IGF: Insuline Growth Factor IL-6: Interleukin 6 iNOS: inducible Nitric Oxide Synthase JNK: Jun N-terminal Kinase KO: Knock Out LGMD1A: Limb Girdle Muscular Dystrophy (type) 1A LGMD1C: Limb Girdle Muscular Dystrophy (type) 1C LGMD2B: Limb Girdle Muscular Dystrophy (type) 2B LGMD2G: Limb Girdle Muscular Dystrophy (type) 2G LGMD2J: Limb Girdle Muscular Dystrophy (type) 2J LIF: Leukemia Inhibitor Factor LPS: Lipopolysaccharide LXA4: Lipoxin A4 MAPK: Mitogen Activated Protein Kinase mdr: multidrug resistant MFM: MyoFibrillar Myopathy MHC: Myosin Heavy Chains MM: Miyoshi Myopathy MRFs: Myogenic Regulatory Factors mpc: muscular progenitors cells MSM: Myosin Storage Myopathy Elenco abbreviazioni - 9 -
Page 1: Unione Europea UNIVERSITÀ DEGLI ST
Page 4 and 5: 2.4.3 IGF pag. 48 2.4.4 TGF-β pag.
Page 6 and 7: 8.6 Microscopia confocale pag. 139
Page 8 and 9: - 2 - Riassunto mioblasti che diffe
Page 10 and 11: - 4 - Abstract Annexin A1 (ANXA1, l
Page 12 and 13: - 6 - Introduzione Il muscolo schel
Page 16 and 17: - 10 - mSP: muscle Side Population
Page 18 and 19: Capitolo 1 Muscolo scheletrico e mi
Page 38 and 39: Capitolo 2 Rigenerazione del muscol
Page 64 and 65:
Capitolo 3 Patologie del muscolo sc
Page 66 and 67:
Page 68 and 69:
Page 70 and 71:
Page 72 and 73:
Page 74 and 75:
Page 76 and 77:
Page 78 and 79:
Page 80 and 81:
Page 82 and 83:
Page 84 and 85:
Page 86 and 87:
Page 88 and 89:
Page 90 and 91:
Page 92 and 93:
Capitolo 4 Annessina A1 1993). Il l
Page 94 and 95:
Capitolo 4 Annessina A1 consenso pe
Page 96 and 97:
Capitolo 4 Annessina A1 tanto da es
Page 98 and 99:
Capitolo 4 Annessina A1 dell‟espr
Page 100 and 101:
Capitolo 4 Annessina A1 L‟espress
Page 102 and 103:
Capitolo 4 Annessina A1 proteina be
Page 104 and 105:
Capitolo 4 Annessina A1 nello svilu
Page 106 and 107:
Capitolo 5 Annessina A1: il volto n
Page 108 and 109:
Page 110 and 111:
Page 112 and 113:
Page 114 and 115:
Page 116 and 117:
Page 118 and 119:
Page 120 and 121:
Page 122 and 123:
Page 124 and 125:
Capitolo 6 Risultati 6.2 siRNAs dir
Page 126 and 127:
Capitolo 6 Risultati Figura 6.8 Imm
Page 128 and 129:
Capitolo 6 Risultati Figura 6.4 (A)
Page 130 and 131:
Capitolo 6 Risultati 6.6 Annessina
Page 132 and 133:
Capitolo 6 Risultati 6.8 L’antico
Page 134 and 135:
Capitolo 6 Risultati Figura 6.13 An
Page 136 and 137:
Capitolo 7 Discussione e Conclusion
Page 138 and 139:
Page 140 and 141:
Page 142 and 143:
Page 144 and 145:
Capitolo 8 Materiali e Metodi serin
Page 146 and 147:
Capitolo 8 Materiali e Metodi serum
Page 148 and 149:
Capitolo 8 Materiali e Metodi - ANX
Page 151 and 152:
Bibliografia Adams GR, McCue SA. 19
Page 153 and 154:
Bibliografia Babbin BA, Lee WY, Par
Page 155 and 156:
Bibliografia Bergstrom DA, Tapscott
Page 157 and 158:
Bibliografia Buckingham M, Tajbakhs
Page 159 and 160:
Bibliografia Chelly J, Hamard G, Ko
Page 161 and 162:
Bibliografia Cornelison DD, Wilcox-
Page 163 and 164:
Bibliografia signaling and promotes
Page 165 and 166:
Bibliografia Faulkner G, Pallavicin
Page 167 and 168:
Bibliografia Galli R, Borello U, Gr
Page 169 and 170:
Bibliografia Greenfield NJ, Fowler
Page 171 and 172:
Bibliografia Hasty P, Bradley A, Mo
Page 173 and 174:
Bibliografia Irintchev A, Zeschnigk
Page 175 and 176:
Bibliografia Kerschbaum HH, Donato
Page 177 and 178:
Bibliografia Kurek J, Bower J, Roma
Page 179 and 180:
Bibliografia Lehtokari VL, Pelin K,
Page 181 and 182:
Bibliografia Matsuda A, Tagawa Y, Y
Page 183 and 184:
Bibliografia Mohiti J, Walker JH, C
Page 185 and 186:
Bibliografia Nicholson GA, Gardner-
Page 187 and 188:
Bibliografia Perez OD, Chang YT, Ro
Page 189 and 190:
Bibliografia Rapraeger AC. 2000. Sy
Page 191 and 192:
Bibliografia Sabourin LA, Girgis-Ga
Page 193 and 194:
Bibliografia Selcen D, Stilling G,
Page 195 and 196:
Bibliografia Solito E, Ahmad K, Rus
Page 197 and 198:
Bibliografia Tajbakhsh S, Borello U
Page 199 and 200:
Bibliografia Tortora G, Grabowski J
Page 201 and 202:
Bibliografia Wallgren-Pettersson C,
Page 203 and 204:
Bibliografia Wright WE, Sassoon DA,
Page 205 and 206:
Bibliografia Zeschnigk M, Kozian D,
show all

Nell'ambito del progetto di ricerca dal titolo “Studio di attività ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?